– Nanna’s unique screening platform has great potential to create novel programs, leading to maximization of mitochondria-related research TOKYO and CAMBRIDGE (UK), April 21, 2020 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Nanna Therapeutics Limited (CEO: David Williams, Ph.D., “Nanna”) today announced that Astellas has acquired Nanna, a […]

Cambridge UK, 2nd May 2018 – Bactevo Ltd. announced today that it has entered into a drug discovery collaboration agreement with Boehringer Ingelheim to identify novel small molecule lead compounds. This collaboration leverages Bactevo’s revolutionary TIME (Totally Integrated Medicines Engine) platform, incorporating its ground-breaking synthetic chemistry technology, designed specifically to combine medicinally-relevant ‘tagless’ chemical diversity […]

Cambridge UK, 9th August 2017 – Bactevo’s Totally Integrated Medicines Engine (TIME) technology has been featured in the latest issue of Genetic Engineering & Biotechnology News (GEN). Click here to read the article. About Bactevo Bactevo has built a unique and game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Utilising its paradigm shift in the speed, efficiency […]

Achieves 100 Million Disease-Relevant Assays per Hour Incorporates Ground-Breaking Synthetic Chemistry Platform Management Team and SAB Expanded to Accelerate Next Phase of Growth 25th April, 2017 CAMBRIDGE, UK – Bactevo Ltd today unveiled a game-changing Totally Integrated Medicines Engine (TIME) capable of 100 million phenotypic assays per hour, a landmark in disease-relevant assay screening. TIME […]

Cambridge UK, 25th January 2017 – Bactevo, the revolutionary Cambridge, UK-based drug discovery company has received an Innovate Award for a prestigious £1.5M grant. Exploiting revolutionary work in the field of integrated, accelerated drug discovery in micro-droplets, Bactevo will progress its programmes focused on generating new antibiotic drugs to highly drug resistant Gram-negative pathogens causing septicaemia, chest […]